NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Medicines Update

For all prescribers and health professionals both in primary care and the acute sector.

News and information blog from ADTC covering clinical topics for all sectors of the NHS.

All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site.  Click here for an index to all previous editions.  If you would like a copy of a previous edition, please contact  medicines.update@ggc.scot.nhs.uk

Retinoid Preparations

Posted: July 10, 2015.
Category - Medicines Update
Tagged with - MHRA Drug Safety Update

Retinoid containing preparations are prescribed in the treatment of severe acne, eczema and psoriasis by physicians with experience in their use. Within NHSGGC, this is generally under the supervision of a consultant dermatologist with prescrip...

Read More...

Ibuprofen Safety Update

Posted: July 10, 2015.
Category - Medicines Update
Tagged with - NSAIDs MHRA Drug Safety Update

The MHRA has published updated advice on cardiovascular risks of high dose ibuprofen and interaction of ibuprofen with aspi...

Read More...

Safety Alert: MinimsĀ® Unit Dose Eye Drops

Posted: July 10, 2015.
Category - Medicines Update
Tagged with - Eye

The manufacturer has removed the labelling on the Minims® unit dose vials. The label previously had an identification code and abbreviated strength printed on the body of the container. The strength is now embossed

Read More...

Heart MCN Key Messages

Posted: July 10, 2015.
Category - Medicines Update
Tagged with - Guidelines Update

Hypertension guidelines The newly revised version of the

Read More...

High strength insulin: safety update

Posted: May 28, 2015.
Category - Medicines Update
Tagged with - Diabetes

Several new high strength insulin products are now on the market. Both Humalog Kwikpen® (insulin lispro) and Tresiba Flextouch® (insulin degludec; non-Formulary) are available as 100units/mL and 200units/mL. There are differences in the...

Read More...

What's new with vitamin D

Posted: May 28, 2015.
Category - Medicines Update
Tagged with - Osteoporosis

New high dose preparations Several new high dose colecalciferol (vitamin D) preparations have recently been licensed in the UK, including:• Aviticol® 20,000 unit capsule• Fultium® D3 20,000 unit...

Read More...

Amiodarone and dronedarone: monitoring

Posted: May 15, 2015.
Category - Medicines Update
Tagged with - Dronedarone

Amiodarone is an effective anti-arrhythmic, but it is associated with significant adverse effects: thyroid toxicity, hepatotoxicity and pulmonary toxicity. SIGN have provided clear guidance on amiodarone use and monitoring to minimise drug rela...

Read More...

Novel psychoactive substances: acute and chronic harms

Posted: May 15, 2015.
Category - Medicines Update

Novel Psychoactive Treatment UK Network (NEPTUNE) was developed to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances. It is aimed at clinicians working in a range of fron...

Read More...

Hydroxyzine and heart rhythm abnormalities

Posted: May 15, 2015.
Category - Medicines Update
Tagged with - MHRA Drug Safety Update

The MHRA have updated prescribing advice for this antihistamine following concerns of heart rhythm abnormalities. A European review concluded that hydroxyzine is associated with a small risk of QT interval prolongation and Torsade de Pointes. S...

Read More...

Temazepam prescribing change 01/06/15

Posted: May 15, 2015.
Category - Medicines Update
Tagged with - Benzodiazepines Formulary Prescribing

For many years, temazepam has been in the anomalous position where although a schedule 3 Controlled Drug (CD), it has been exempt from the prescription writing requirements that apply to all other schedule 2 and 3 CDs. The Home Office has recen...

Read More...